Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genome wide association study of human bacteremia Escherichia coli isolates identifies genetic determinants for the portal of entry but not fatal outcome

View ORCID ProfileErick Denamur, View ORCID ProfileBénédicte Condamine, Marina Esposito-Farèse, View ORCID ProfileGuilhem Royer, View ORCID ProfileOlivier Clermont, View ORCID ProfileCédric Laouenan, Agnès Lefort, View ORCID ProfileVictoire de Lastours, View ORCID ProfileMarco Galardini, the COLIBAFI, SEPTICOLI groups
doi: https://doi.org/10.1101/2021.11.09.21266136
Erick Denamur
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
2Laboratoire de Génétique Moléculaire, Hôpital Bichat, AP-HP, F-75018 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erick Denamur
  • For correspondence: marco.galardini@twincore.de erick.denamur@inserm.fr
Bénédicte Condamine
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bénédicte Condamine
Marina Esposito-Farèse
3Département d’épidémiologie, biostatistiques et recherche clinique, Hôpital Bichat, AP-HP, F-75018 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guilhem Royer
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
4LABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université Paris-Saclay, Evry, France
5Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, F-94000 Créteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guilhem Royer
Olivier Clermont
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Clermont
Cédric Laouenan
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
3Département d’épidémiologie, biostatistiques et recherche clinique, Hôpital Bichat, AP-HP, F-75018 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cédric Laouenan
Agnès Lefort
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
6Service de Médecine Interne, Hôpital Beaujon, AP-HP, F-92100 Clichy, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victoire de Lastours
1Université de Paris, IAME, UMR 1137, INSERM, Paris F-75018, France
6Service de Médecine Interne, Hôpital Beaujon, AP-HP, F-92100 Clichy, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victoire de Lastours
Marco Galardini
7Institute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany
8Cluster of Excellence RESIST (EXC 2155), Hannover Medical School (MHH), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Galardini
  • For correspondence: marco.galardini@twincore.de erick.denamur@inserm.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Escherichia coli is an important cause of bloodstream infections (BSI), which is of concern given its high mortality and increasing worldwide prevalence. Finding bacterial genetic variants that might contribute to patient death is of interest to better understand its mechanism and implement diagnostic methods that specifically look for those factors. E. coli samples isolated from patients with BSI are an ideal dataset to systematically search for those variants, as long as the influence of host factors such as comorbidities are taken into account. Here we performed a genome-wide association study (GWAS) using data from 910 patients with E. coli BSI from hospitals in Paris, France; we looked for associations between bacterial genetic variants and three patient outcomes (death at 28 days, septic shock and admission to intensive care unit), as well as two portals of entry (urinary and digestive tract), using various clinical variables from each patient to account for host factors. We did not find any associations between genetic variants and patient outcomes, potentially confirming the strong influence of host factors in influencing the course of BSI; we however found a strong association between the papGII/papGIII operon and entrance of E. coli through the urinary tract, which demonstrates the power of bacterial GWAS even when applied to actual clinical data. Despite the lack of associations between E. coli genetic variants and patient outcomes, we estimate that increasing the sample size by one order of magnitude could lead to the discovery of some putative causal variants. The adoption of bacterial genome sequencing of clinical isolates might eventually lead to the elucidation of the mechanisms behind BSI progression and the development of sequence-based diagnostics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially funded by a Translational Research Grant from the Agence Nationale de la Recherche (ANR), Ministry of Higher Education and Research, France 2015 (grant n ANR-15-CE-17-0019-01). ED was partially supported by the "Fondation pour la Recherche Medicale" (Equipe FRM 2016, grant number DEQ20161136698). GR was supported by a "Poste d'accueil" funded by the "Assistance Publique-Hopitaux de Paris" (AP-HP) and the "Commissariat a' l'energie atomique et aux energies alternatives" (CEA) personal grant for his PhD. MG was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy - EXC 2155 - project number 390874280.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Both multicenter clinical trials were approved by ethic committees. The Colibafi study was approved by the French Comite' de Protection des Personnes of Hopital Saint-Louis, Paris, France (approval #2004-06, June 2004). The Septicoli study was approved by the French Comite' de Protection des Personnes Ile de France n IV (IRB 00003835, March 2016) and was registered on clinical trials in September 2016 (ClinicalTrials.gov Identifier: NCT02890901). Because of their non-interventional nature, only an oral consent from patients was requested under French law. Both studies conformed to the principles of the Helsinki declaration.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* The names of the collaborators are listed in the Acknowledgement section.

Data Availability

All data produced in the present work are contained in the manuscript and are available in public repositories such as ENA and github

https://github.com/microbial-pangenomes-lab/2021_ecoli_pathogenicity

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 11, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genome wide association study of human bacteremia Escherichia coli isolates identifies genetic determinants for the portal of entry but not fatal outcome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genome wide association study of human bacteremia Escherichia coli isolates identifies genetic determinants for the portal of entry but not fatal outcome
Erick Denamur, Bénédicte Condamine, Marina Esposito-Farèse, Guilhem Royer, Olivier Clermont, Cédric Laouenan, Agnès Lefort, Victoire de Lastours, Marco Galardini, the COLIBAFI, SEPTICOLI groups
medRxiv 2021.11.09.21266136; doi: https://doi.org/10.1101/2021.11.09.21266136
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genome wide association study of human bacteremia Escherichia coli isolates identifies genetic determinants for the portal of entry but not fatal outcome
Erick Denamur, Bénédicte Condamine, Marina Esposito-Farèse, Guilhem Royer, Olivier Clermont, Cédric Laouenan, Agnès Lefort, Victoire de Lastours, Marco Galardini, the COLIBAFI, SEPTICOLI groups
medRxiv 2021.11.09.21266136; doi: https://doi.org/10.1101/2021.11.09.21266136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)